tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Depth

tanzania times : Latest News and In-depth Analysis
HomeDepth
Depth

Feb 10, 2025

CLPS Incorporation Announces the Launch of Nibot RPA Product, Expanding Automation Services into the Global Market

HONG KONG,Feb. 7,2025-- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS),today announced the launch of Nibot,a new generation of Robotic Process Automation (RPA) product

All News

WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)

SHANGHAI,Jan. 13,2025-- WuXi AppTec,a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industries,announ

Jan 13, 2025

Depth

iM Global Partner mourns the passing of Philippe Uzan

PARIS,Jan. 13,2025--It is with deep sadness thatiM Global Partner (iMGP) announces the passing,one month ago,of our dear friend and colleague,Philippe Uzan.

Jan 13, 2025

Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery

Funding from leading investors to accelerate R&D and international expansion to make robotic surgery solutions accessible to more

Jan 13, 2025

Depth

LANDI Global Unveils Flagship Cx20: Elevating business efficiency and customer experience with a next-generation Windows-powered terminal

SINGAPORE,Jan. 11,2025-- LANDI Global proudly announces the launch of the Cx20 terminal,our flagship next-generation smart Windows Desktop POS.

Jan 13, 2025

Global Times: Nearly 80% of foreign respondents show confidence in China’s development prospect in first survey on China’s international image

As changes unseen in a century accelerate across the world, China's impact is becoming increasingly comprehensive, profound, and long-lasting. The global attention on China has never been as wide, deep, and focused as it is today.

Jan 13, 2025

Depth

SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA

SEOUL,South Korea,Jan. 10,2025-- SNBioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a

Jan 11, 2025

1 ... 24 25 26 27 28 29 30